CMAB806 (tocilizumab biosimilar) / Jinyu Biotech - LARVOL DELTA

A Multicenter, Randomized, Double-Blind, Parallel Group, Positive Drug Control Evaluation of the Efficacy and Safety of CMAB806 in Combination with Methotrexate for the Treatment of Adult Patients with Moderate to Severe Active Rheumatoid Arthritis (ChiCTR) - P3 | N=624 | Completed | Sponsor: Peking University People's Hospital; JINJU BOWORUNZE BIOTECHNOLOGY CO., LTD.

New P3 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology • CRP

ASH 2020: Managing CAR T Side Effects in Multiple Myeloma (Myeloma Crowd) - "CAR T therapy side effects are potentially consequential for multiple myeloma patients, but myeloma experts are now more experienced at managing them well...Dr. Raje also stressed caregivers are essential to help identify early symptoms and help care teams determine if patients are acting normally or seem out of sorts. Responding quickly to any abnormal behavior is key. Dr. Raje shared the safety profile of three separate CAR T clinical trials at annual American Society of Hematology (ASH) meeting."

Media quote